Communications medicine
HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir.
Gilbert Mchantaf, Adeline Melard, Kévin Da Silva, Elise Gardiennet, Antoine Chaillon, Bénédicte Lefebvre, Jade Ghosn, Olivier Robineau, Jean-Paul Viard, Lucie Adoux, Frédéric Lemoine, Aurélie Barrail-Tran, Sylvie Orr, Fatoumata Coulibaly, Laurence Meyer
Published: 202610.1038/s43856-026-01405-z
Abstract
BACKGROUND: Relatively few studies have investigated HIV-1 persistence in tissues, especially in healthy people-living-with-HIV-1 (PLWH) on a successful antiretroviral regimen containing second generation integrase inhibitors. METHODS: In the ANRS EP…
Preview only. Read the full abstract at the source